These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 30133843)

  • 1. Effect of Delaying Replacement of Parenteral Nutrition Intravenous Administration Sets: Preclinical Experiments and a Dynamic Laboratory Model of Microbial Colonization.
    Gavin NC; McMillan D; Keogh S; Choudhury MA; Ray-Barruel G; Rickard CM
    JPEN J Parenter Enteral Nutr; 2018 Aug; 42(6):987-997. PubMed ID: 30133843
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Does delaying early intravenous fat emulsion during parenteral nutrition reduce infections during critical illness?
    Gerlach AT; Thomas S; Murphy CV; Stawicki PS; Whitmill ML; Pourzanjani L; Steinberg SM; Cook CH
    Surg Infect (Larchmt); 2011 Feb; 12(1):43-7. PubMed ID: 21166636
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of 24-hour intravenous tubing set change on the sterility of repackaged fat emulsion in neonates.
    Reiter PD; Robles J; Dowell EB
    Ann Pharmacother; 2004 Oct; 38(10):1603-7. PubMed ID: 15328398
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Infectious complications with nondaily versus daily infusion of intravenous fat emulsions in non-critically ill adults.
    Chheng ML; Heidbreder C; Btaiche IF; Blackmer AB
    Nutr Clin Pract; 2013 Dec; 28(6):737-44. PubMed ID: 24192265
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A new central venous catheter cap: decreased microbial growth and risk for catheter-related bloodstream infection.
    Buchman AL; Spapperi J; Leopold P
    J Vasc Access; 2009; 10(1):11-21. PubMed ID: 19340794
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A randomized trial of 72- versus 24-hour intravenous tubing set changes in newborns receiving lipid therapy.
    Matlow AG; Kitai I; Kirpalani H; Chapman NH; Corey M; Perlman M; Pencharz P; Jewell S; Phillips-Gordon C; Summerbell R; Ford-Jones EL
    Infect Control Hosp Epidemiol; 1999 Jul; 20(7):487-93. PubMed ID: 10432161
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Total nutrient admixtures appear safer than lipid emulsion alone as regards microbial contamination: growth properties of microbial pathogens at room temperature.
    Didier ME; Fischer S; Maki DG
    JPEN J Parenter Enteral Nutr; 1998; 22(5):291-6. PubMed ID: 9739032
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Review of Intravenous Lipid Emulsion Therapy.
    Spray JW
    J Infus Nurs; 2016; 39(6):377-380. PubMed ID: 27828934
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Epidemiology of bloodstream infection associated with parenteral nutrition.
    Opilla M
    Am J Infect Control; 2008 Dec; 36(10):S173.e5-8. PubMed ID: 19084152
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Microbial growth patterns in a total parenteral nutrition formulation containing lipid emulsion.
    Gilbert M; Gallagher SC; Eads M; Elmore MF
    JPEN J Parenter Enteral Nutr; 1986; 10(5):494-7. PubMed ID: 3093706
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Systematic review and meta-analyses of the effect of lipid emulsion on microbial growth in parenteral nutrition.
    Austin PD; Hand KS; Elia M
    J Hosp Infect; 2016 Dec; 94(4):307-319. PubMed ID: 27765342
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Parenteral MCT/ω-3 Polyunsaturated Fatty Acid-Enriched Intravenous Fat Emulsion Is Associated With Cytokine and Fatty Acid Profiles Consistent With Attenuated Inflammatory Response in Preterm Neonates: A Randomized, Double-Blind Clinical Trial.
    Skouroliakou M; Konstantinou D; Agakidis C; Kaliora A; Kalogeropoulos N; Massara P; Antoniadi M; Panagiotakos D; Karagiozoglou-Lampoudi T
    Nutr Clin Pract; 2016 Apr; 31(2):235-44. PubMed ID: 26378118
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The growth of microorganisms in total parenteral nutrition admixtures.
    D'Angio R; Quercia RA; Treiber NK; McLaughlin JC; Klimek JJ
    JPEN J Parenter Enteral Nutr; 1987; 11(4):394-7. PubMed ID: 3112431
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Factors Influencing Escherichia coli and Enterococcus durans Growth in Parenteral Nutrition With and Without Lipid Emulsion to Inform Maximum Duration of Infusion Policy Decisions.
    Austin PD; Hand KS; Elia M
    JPEN J Parenter Enteral Nutr; 2015 Nov; 39(8):953-65. PubMed ID: 24969406
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Three-in-one parenteral nutrition in neonates and pediatric patients: risks and benefits.
    Blackmer AB; Partipilo ML
    Nutr Clin Pract; 2015 Jun; 30(3):337-43. PubMed ID: 25857309
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The use of IV fat in neonates.
    Kerner JA; Poole RL
    Nutr Clin Pract; 2006 Aug; 21(4):374-80. PubMed ID: 16870805
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Bacterial/fungal growth in a combined parenteral nutrition solution.
    Mershon J; Nogami W; Williams JM; Yoder C; Eitzen HE; Lemons JA
    JPEN J Parenter Enteral Nutr; 1986; 10(5):498-502. PubMed ID: 3093707
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Repackaging of Intravenous Fat Emulsions: A Clinical Conundrum.
    Cober MP
    Nutr Clin Pract; 2016 Oct; 31(5):642-6. PubMed ID: 27521143
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Growth of microorganisms in total parenteral nutrition mixtures and related clinical observations.
    Scott EM; Gorman SP; Wyatt TD; Magill EA
    J Clin Hosp Pharm; 1985 Mar; 10(1):79-88. PubMed ID: 3923044
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A.S.P.E.N. clinical guidelines: parenteral nutrition ordering, order review, compounding, labeling, and dispensing.
    Boullata JI; Gilbert K; Sacks G; Labossiere RJ; Crill C; Goday P; Kumpf VJ; Mattox TW; Plogsted S; Holcombe B;
    JPEN J Parenter Enteral Nutr; 2014; 38(3):334-77. PubMed ID: 24531708
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.